ZJYL Valuation
Jin Medical International Ltd
$
0.570
- Overview
- Forecast
- Valuation
- Earnings
ZJYL Relative Valuation
ZJYL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZJYL is overvalued; if below, it's undervalued.
Historical Valuation
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Jin Medical International Ltd. (ZJYL) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Jin Medical International Ltd. (ZJYL) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Jin Medical International Ltd. (ZJYL) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Jin Medical International Ltd. (ZJYL) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Jin Medical International Ltd. (ZJYL) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Jin Medical International Ltd (ZJYL) has a current Price-to-Book (P/B) ratio of NaN. Compared to its 3-year average P/B ratio of 12.02 , the current P/B ratio is approximately NaN% higher. Relative to its 5-year average P/B ratio of 12.02, the current P/B ratio is about NaN% higher. Jin Medical International Ltd (ZJYL) has a Forward Free Cash Flow (FCF) yield of approximately NaN%. Compared to its 3-year average FCF yield of 1.21%, the current FCF yield is approximately NaN% lower. Relative to its 5-year average FCF yield of 1.21% , the current FCF yield is about NaN% lower.
3.20
P/B
Median3y
12.02
Median5y
12.02
-0.88
FCF Yield
Median3y
1.21
Median5y
1.21
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ZJYL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ZJYL in the past 1 year is driven by Unknown.
People Also Watch
RMBI
Richmond Mutual Bancorporation Inc
14.810
USD
+2.70%
MDV
Modiv Industrial Inc
15.090
USD
+2.79%
VTYX
Ventyx Biosciences Inc
2.390
USD
+3.46%
VERU
Veru Inc
3.570
USD
+4.39%
NBTX
Nanobiotix SA
12.310
USD
+20.65%
SGHT
Sight Sciences Inc
3.690
USD
+7.89%
FRGE
Forge Global Holdings Inc
17.880
USD
+11.54%
KYTX
Kyverna Therapeutics Inc
5.010
USD
+14.65%
MPAA
Motorcar Parts of America Inc
16.490
USD
+3.06%
INMB
INmune Bio Inc
1.970
USD
+3.14%
FAQ
Is Jin Medical International Ltd (ZJYL) currently overvalued or undervalued?
Jin Medical International Ltd (ZJYL) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of 0.00. The fair price of Jin Medical International Ltd (ZJYL) is between to according to relative valuation methord.
What is Jin Medical International Ltd (ZJYL) fair value?
How does ZJYL's valuation metrics compare to the industry average?
What is the current P/B ratio for Jin Medical International Ltd (ZJYL) as of Sep 19 2025?
What is the current FCF Yield for Jin Medical International Ltd (ZJYL) as of Sep 19 2025?
What is the current Forward P/E ratio for Jin Medical International Ltd (ZJYL) as of Sep 19 2025?